Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Thyroid medication

If sedatives, barbiturates, antipsychotic drugs, stimulants, opiates and thyroid medications all outperform inert placebos in the treatment of depression, does this mean that any active drug can function as an antidepressant Apparently not. In September 1998 the pharmaceutical company Merck announced the discovery of a novel antidepressant with a completely different mode of action than other medications for depression. This new drug, which they later marketed under the trade name Emend for the prevention of nausea and vomiting due to chemotherapy, seemed to show considerable promise as an antidepressant in... [Pg.13]

At first, Sapirstein and I found the equivalence between antidepressants and other drugs puzzling, to say the least. Why should drugs that are not antidepressants be as effective as antidepressants in treating depression To answer this question, we asked another. What do all these diverse drugs have in common that they do not share with inert placebos What do SSRIs have in common with the older tricyclic antidepressants, with other less common antidepressants, and even with tranquillizers, depressants and thyroid medication The only common factor that we were able to note was that they all produce easily noticeable side effects - the one thing that was lacking in Merck s new treatment for depression. Placebos can also produce side effects, but they do so to a much lesser extent than active medication. Clinical trials show that whereas the therapeutic benefits of antidepressants are relatively small when compared to placebos, the difference in side effects is substantial.7... [Pg.14]

After some adjustment problems I was able to take a thyroid medication, in small amounts. That was a pivotal point, and I was able to expand the foods I could eat. By January 1990 I was up to six foods, including a grain, which I hadn t been able to eat in a year and a half. I worked up to being able to stand and walk for up to an hour a day. That period lasted about three months, until one day a nerve in my foot became so inflamed that when I stepped out of my car it felt like a tack was rammed into my foot. I ve never really recovered from that relapse, which happened ten years ago. [Pg.43]

Trace amounts of iodine are required for a healthy body. Iodine is part of the hormone thyroxin produced by the thyroid gland. Thyroid secretions control the physical and mental development of the human body. A goiter, a swelling of the thyroid gland, is caused by the lack of iodine. Adding thyroid medication and iodized salt to the diet helps prevent this disease. Radioactive iodine (1-131), with a half-life of eight days, is used to treat some diseases of the thyroid gland. [Pg.256]

Cardiovascular disorders Use with extreme caution in patients with cardiovascular disorders because of the possibility of conduction defects, arrhythmias, CHF, sinus tachycardia. Ml, strokes, and tachycardia. These patients require cardiac surveillance at all dose levels of the drug. In high doses, TCAs may produce arrhythmias, sinus tachycardia, conduction defects, and prolonged conduction time. Tachycardia and postural hypotension may occur more frequently with protriptyline. Hyperthyroid patients Hyperthyroid patients or those receiving thyroid medication require close supervision because of the possibility of cardiovascular toxicity, including arrhythmias. [Pg.1039]

Alcohol and some drugs can also affect calcium levels in the body, thus producing osteoporosis. Some of these drugs include thyroid medications, steroid preparations, anti-seizure medications, and certain chemotherapy (anti-cancer) agents. [Pg.697]

Treatment of secondary osteoporosis varies depending on the actual disease process which has produced the osteoporosis, and may include adjustments to thyroid medication, dietary supplementation with calcium or vitamin D (which is involved in the ability of the intestine to absorb calcium in the diet), or other treatment of the primary disease. [Pg.698]

Concomitant use with thyroid medication, pimozole, and antiarrhythmic agents (quinidine, disopyramide, procainamide) may increase incidence of cardiac arrhythmias and conduction defects. [Pg.710]

The New Mexico Elder Health Survey was a study of health issues in subjects older than 65 years, divided equally between Hispanic and non-Hispanic men and women selected randomly from the Medicare rolls of the city of Albuquerque. A cross-sectional study of 825 persons found 12.8% already on thyroid medications, one-third of whom had elevated TSH levels. Another 15.4% had elevated TSH levels on screening. Figure 105.2 shows the distribution of TSH. Hispanic subjects had lower rates of hypothyroidism than whites, but this was significant only for women overall, women were almost three times more likely to be hypothyroid than men (Lindeman etal., 1999). [Pg.1031]

Thyroid medications do not affect the client s blood glucose level therefore, there is no need for the client to monitor the glucose level. [Pg.161]

Normal routine doses of thyroid medication would not interfere with a sleep study. [Pg.315]

Kaplan JA, CoopeimanLH. Alarming reactions to ketamine in patients taking thyroid medication — treatment with propranolol. Anesthesiology (1971) 35,229-30. [Pg.100]

Health Canada s Natural Health Products Directorate (NHPD) has concluded that daily use by healthy adults of p-synephrine at up to 50 mg, or up to 40 mg in combination with up to 320 mg of caffeine, would generally result in a Type III risk classification. This classification is defined to mean that such use "is not likely to cause any adverse health consequences." On the other hand, NHPD determined that products that contain p-synephrine but lack certain cautionary statements, identified as "contraindicated in children, pregnancy, and breast-feeding, do not use if you are taking blood pressure medications (either hypertensives or antihypertensives), thyroid medications, sympathomimetics, or monoamine oxidase inhibitors," would be subject to a Type II risk classification (meaning "the use of, or exposure to, such a product may cause temporary adverse hedth consequences or where the probability of serious adverse health consequences is remote") (Maries 2011). [Pg.223]

None known, although use with thyroid medications should be under the supervision of a qualified healthcare practitioner (Bradley 2006). [Pg.382]

In hypothyroidism calcium and phosphorus excretions are generally decreased, becoming normal with thyroid medication. No evidence of denser bone formation has resulted from radiographic studies of this condition. ... [Pg.421]


See other pages where Thyroid medication is mentioned: [Pg.669]    [Pg.198]    [Pg.62]    [Pg.138]    [Pg.1371]    [Pg.1381]    [Pg.67]    [Pg.93]    [Pg.39]    [Pg.507]    [Pg.945]    [Pg.1027]    [Pg.1028]    [Pg.1159]    [Pg.1275]    [Pg.166]    [Pg.302]    [Pg.9]    [Pg.8]    [Pg.360]    [Pg.99]    [Pg.39]   
See also in sourсe #XX -- [ Pg.13 ]

See also in sourсe #XX -- [ Pg.155 , Pg.168 ]




SEARCH



Thyroid System Medication

© 2024 chempedia.info